Post Hoc Analyses of Surrogate Markers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis in Patients With Type 2 Diabetes in a Digitally Supported Continuous Care InterventionPublished on May 24, 2019Read More